このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

SIRI Levels Following PENG Block in Hip Arthroplasty

2026年11月3日 更新者:Poznan University of Medical Sciences

外被神経群ブロックは全人工股関節置換術における手術侵襲を軽減し、鎮痛効果を増強する:無作為化比較試験

This randomized controlled trial evaluates the effect of ultrasound-guided Pericapsular Nerve Group (PENG) block on the Systemic Inflammation Response Index (SIRI) in elderly patients undergoing total hip arthroplasty under spinal anesthesia. SIRI, calculated as neutrophil count × monocyte count / lymphocyte count, is used as a composite marker of perioperative inflammatory response. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block. The study investigates whether PENG block attenuates the systemic inflammatory reaction to surgical trauma compared to sham block.

調査の概要

状態

完了

条件

介入・治療

詳細な説明

Surgical trauma induces a systemic inflammatory response characterized by neutrophilia, lymphopenia, and platelet activation. These hematologic alterations reflect the interaction between innate immune activation, stress-induced immunosuppression, and pro-thrombotic mechanisms. The modulation of this response may influence postoperative recovery and complication risk.

The Systemic Inflammation Response Index (SIRI) is calculated as neutrophil count × monocyte count / lymphocyte count. It incorporates neutrophils and monocytes in relation to lymphocytes as a composite marker of systemic inflammation. This study evaluates whether PENG block influences postoperative SIRI in patients undergoing total hip arthroplasty.

The primary objective of this study is to compare SIRI at 12 hours after surgery between the PENG block and sham block groups in elderly patients undergoing total hip arthroplasty under spinal anesthesia.

Peripheral venous blood samples will be collected preoperatively and at 12, 24, and 48 hours after surgery. The primary endpoint is SIRI at 12 hours after surgery.

This study aims to determine whether motor-sparing regional anesthesia may modulate systemic inflammatory response beyond analgesic effects, potentially contributing to improved perioperative outcomes.

研究の種類

介入

入学 (実際)

60

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Poznan、ポーランド、62-701
        • Poznan University of Medical Sciences

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

65年~100年 (高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patients with ASA classification I-III
  • Aged 65-100 years
  • Who will be scheduled for hip arthroplasty under spinal anesthesia

Exclusion Criteria:

  • Patients who have a history of bleeding diathesis
  • Take anticoagulant therapy
  • History of chronic pain before surgery
  • Multiple trauma
  • patients unable to assess their pain (dementia)
  • patients operated under general anesthesia
  • patients having an infection in the region of the procedure
  • the patient who does not accept the procedure

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:4倍

武器と介入

参加者グループ / アーム
介入・治療
偽コンパレータ:Sham blocks

PENG block with 20ml of 0.9% sodium chloride

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20ml of 0.9% sodium chloride

他の名前:
  • 0.9%塩化ナトリウム注射液
アクティブコンパレータ:PENG block

PENG block with 20ml 0f 0.2% ropivacaine

After spinal anesthesia, the ultrasound-guided PENG block will be performed with 20 ml of 0.2% ropivacaine

他の名前:
  • 0.2% ロピバカイン

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Systemic Inflammation Response Index (SIRI)
時間枠:12 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

12 hours after surgery

二次結果の測定

結果測定
メジャーの説明
時間枠
Systemic Inflammation Response Index (SIRI)
時間枠:24 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

24 hours after surgery
Systemic Inflammation Response Index (SIRI)
時間枠:48 hours after surgery

Systemic Inflammation Response Index (SIRI) is used as a composite marker of systemic inflammatory activation. It is calculated from peripheral venous blood samples using the formula:

SIRI = (Neutrophil count × Monocyte count) / Lymphocyte count All parameters are obtained from routine complete blood count (CBC) analysis and expressed in ×10⁹/L.

SIRI reflects the interaction between innate immune activation (neutrophils and monocytes) and adaptive immune suppression (lymphocytes). Higher SIRI values indicate greater systemic inflammatory response.

48 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
時間枠:12 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

12 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
時間枠:24 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

24 hours after surgery
Aggregate Index of Systemic Inflammation (AISI)
時間枠:48 hours after surgery

Aggregate Index of Systemic Inflammation (AISI) is calculated as:

AISI = (Neutrophil count × Monocyte count × Platelet count) / Lymphocyte count All values are obtained from routine CBC and expressed in ×10⁹/L. AISI integrates neutrophils, monocytes, platelets, and lymphocytes, providing a broader assessment of systemic inflammatory and immune response compared to single ratios.

48 hours after surgery
Platelet Mass Index (PMI)
時間枠:12 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

12 hours after surgery
Platelet Mass Index (PMI)
時間枠:24 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

24 hours after surgery
Platelet Mass Index (PMI)
時間枠:48 hours after surgery

Platelet Mass Index (PMI) reflects total circulating platelet mass and is calculated as:

PMI = Platelet count × Mean Platelet Volume (MPV) Platelet count is expressed in ×10⁹/L and MPV in femtoliters (fL). PMI reflects platelet activation and thrombo-inflammatory potential, which may increase in response to surgical stress.

48 hours after surgery
C-reactive Protein (CRP) Concentration
時間枠:12 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

12 hours after surgery
C-reactive Protein (CRP) Concentration
時間枠:24 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

24 hours after surgery
C-reactive Protein (CRP) Concentration
時間枠:48 hours after surgery

C-reactive protein (CRP) is a laboratory marker of acute systemic inflammation measured in peripheral venous blood samples.

CRP concentration is expressed in mg/L and determined using standard hospital laboratory methods.

Higher CRP values indicate greater postoperative inflammatory response.

48 hours after surgery
Postoperative Pain Intensity (NRS)
時間枠:4 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

4 hours after surgery
Postoperative Pain Intensity (NRS)
時間枠:8 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

8 hours after surgery
Postoperative Pain Intensity (NRS)
時間枠:12 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

12 hours after surgery
Postoperative Pain Intensity (NRS)
時間枠:24 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

24 hours after surgery
Postoperative Pain Intensity (NRS)
時間枠:48 hours after surgery

Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where:

0 = no pain 10 = worst pain imaginable Pain scores will be recorded at rest.

48 hours after surgery
Opioid Consumption
時間枠:48 hours after surgery

Total opioid consumption within the first 48 hours after surgery will be recorded.

All administered opioids will be converted to intravenous morphine milligram equivalents (MME) for standardization.

Higher cumulative MME indicates greater analgesic requirement.

48 hours after surgery
Time to First Rescue Analgesia
時間枠:48 hours after surgery

Time from completion of surgery to first administration of rescue opioid analgesia.

Measured in minutes. Shorter time indicates earlier breakthrough pain.

48 hours after surgery

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年3月1日

一次修了 (実際)

2026年9月30日

研究の完了 (実際)

2026年10月2日

試験登録日

最初に提出

2026年2月27日

QC基準を満たした最初の提出物

2026年2月27日

最初の投稿 (実際)

2026年3月4日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月6日

QC基準を満たした最後の更新が送信されました

2026年11月3日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 80/26

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

De-identified individual participant data (IPD) underlying the results reported in publications (including demographic data, laboratory inflammatory indices such as SII, SIRI, AISI, CRP values, pain scores, opioid consumption, and time-to-event outcomes) will be made available to qualified researchers.

Data will be shared after removal of all direct identifiers in accordance with GDPR regulations and institutional data protection policies.

The study protocol, statistical analysis plan (SAP), and analytic code will also be available upon reasonable request.

Data will be provided for the purpose of secondary analyses, meta-analyses, or validation studies, subject to approval by the principal investigator and institutional review board, where applicable.

IPD 共有時間枠

Data will become available 6 months after publication of the primary results and will remain available for 5 years.

IPD 共有アクセス基準

Access will be granted to researchers who provide:

A methodologically sound research proposal Institutional affiliation Ethical approval (if required) A signed data use agreement Requests should be directed to the principal investigator via institutional email.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。